Trial Profile
Prospective, randomized, open-label, clinical trial comparing the effects of irbesartan and valsartan on blood pressure, endothelial function and markers for obesity/oxidative stress/chronic kidney diseases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary) ; Valsartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 12 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 02 Jun 2011 New trial record